Nucleic acid detection system, nucleic acid detection system array, nucleic acid detection method, and method for screening candidate guide nucleic acid

By combining Cas12, Cas13 or Cas14 enzymes with GFETs, a two-step nucleic acid detection method was used to solve the problem of insufficient sensitivity, specificity and applicability of the existing CRISPR chips in target nucleic acid detection, and high sensitivity and high specificity were achieved and the effect of applicability of nucleic acid detection.

CN119020469APending Publication Date: 2024-11-26TSINGHUA UNIVERSITY +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310594867.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-24
Publication Date
2024-11-26

Smart Images

  • Figure CN119020469A_ABST
    Figure CN119020469A_ABST
Patent Text Reader

Abstract

The present invention relates to a nucleic acid detection system, a nucleic acid detection system array, a nucleic acid detection method, and a method for screening candidate guide nucleic acids. The nucleic acid detection system comprises: a substrate comprising a substrate surface and at least two electrodes; the connecting molecule is provided with a first ligand combined with the surface of the substrate and a second ligand combined with the Cas enzyme; a Cas enzyme bound to the second ligand of the linker molecule and forming an enzyme complex with the guide nucleic acid, the Cas enzyme comprising at least one selected from the group consisting of Cas12 (VA) type, Cas13 (VI) type and Cas14 (VF) type; a guide nucleic acid comprising sequences capable of binding to the enzyme and the target nucleic acid, respectively; and a reporter nucleic acid, the reporter nucleic acid comprising a non-specific sequence. The nucleic acid detection system provided by the invention has the advantages of high sensitivity, high specificity and good applicability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a nucleic acid detection system for detecting a target nucleic acid in a sample, a nucleic acid detection system array, a nucleic acid detection method and a method for screening candidate guide nucleic acids. The nucleic acid detection system of the present invention is a graphene-based amplification-free nucleic acid detection system. Background Art

[0002] Most of the existing nucleic acid detection methods require a large amount of reagents and expensive and bulky instruments. Traditional nucleic acid detection techniques such as PCR technology require multi-step reactions to amplify samples, and further improvements are needed in terms of cost and integration. In response to this, a field-effect transistor (GFET, Graphene Field-Effect Transistors) based on graphene has been developed in the prior art. The transistor uses the technology of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats) to achieve digital detection of target sequences in a complete genome (see non-patent document 1, patent document 1). Graphene has the characteristics of huge specific surface area, no hanging bonds, high carrier concentration and carrier mobility, and easy adjustment of band structure, so that its surface is easy to sense small charge changes, so that it can be used to monitor biochemical reactions (see non-patent document 2). GFET is a field effect transistor chip made of graphene as the channel material. The chip uses a solution environment to construct a liquid gate. When a biochemical reaction occurs on the graphene surface, a small charge change will affect the carrier state of the graphene, thereby causing the current through the graphene channel to change and the isoelectric point (also known as the Dirac point) of the graphene transfer curve to move. Due to the characteristics of no label, high sensitivity, low cost, miniature portability, and real-time detection, GFET is a biochemical sensor with great potential, which can be widely used to detect metal ions, proteins, nucleic acids, organic molecules, nucleic acids, etc. (see non-patent document 3). This biosensor called CRISPR chip recorded in non-patent document 1 and patent document 1 uses the gene targeting ability of catalytically inactivated CRISPR-associated protein 9 (Cas9) compounded with a specific single guide RNA and fixed on a transistor to form a nucleic acid detection device that does not require labeling, and its output signal can be measured by a simple reader. In the presence of genomic DNA containing the target gene, the CRISPR chip can generate a current signal with a sensitivity of 1.7fM within 15 minutes, without the need for amplification, and the output signal is significantly enhanced compared to samples without target sequences. The development of the CRISPR chip has greatly expanded the application of CRISPR-Cas9 technology in nucleic acid chip electrical detection.

[0003] Prior art literature

[0004] Patent Literature

[0005] Patent document 1: US20190112643A

[0006] Non-patent literature

[0007] Non-patent literature 1: Hajian, Reza, et al. "Detection of unamplified target genes via CRISPR–Cas9 immobilized on a graphene field-effect transistor." Naturebiomedical engineering 3.6 (2019): 427-437.

[0008] Non-patent document 2: GEIM AK, NOVOSELOV KS. “The rise of graphene [J]”. Nature Materials, 2007, 6 (3): 183-91.

[0009] Non-patent document 3: SADIGHBAYAN D et al. "Biosensing based on field-effecttransistors (FET): Recent progress and challenges [J]". TrAC Trends in AnalyticalChemistry, 2020, 133(116067). Summary of the invention

[0010] Problems to be solved by the invention

[0011] However, the above CRISPR chip has the following problems:

[0012] 1. Sensitivity needs to be improved: The change in graphene surface charge caused by the binding of Cas9 to the target nucleic acid requires the introduction of a new mechanism to achieve better sensitivity. In addition, the binding stability and efficiency of Cas9 to nucleic acid will also affect the detection of target nucleic acid.

[0013] 2. Specificity needs to be improved: Cas9's off-target or non-specific binding to non-target nucleic acids may cause the generation of false signals.

[0014] 3. Applicability needs to be improved: The single enzyme cleavage activity of Cas9 can only bring about a signal change of the graphene chip once by binding to the endogenous target sequence of the nucleic acid to be tested, but cannot amplify the signal detection method through artificial intervention (such as optimization of secondary signals).

[0015] In view of the problems in the above-mentioned prior art, the inventors have conducted in-depth and detailed research and found that by combining Cas12 (VA type), Cas13 (VI type), Cas14 (VF type) or other enzymes with associated cleavage activity with GFETs and performing two-step nucleic acid detection, high sensitivity, high specificity, and good applicability of amplification-free nucleic acid detection can be achieved. Specifically, the method of the present invention can be expected to have the following effects:

[0016] 1. It has higher sensitivity. Enzymes such as Cas12 have higher nucleic acid recognition, binding stability and binding efficiency, and cause a higher increase in signal compared to Cas9.

[0017] 2. High specificity: In the method of the present invention, false positive signals that may be generated by primary shearing (for example, false positive signals caused by unstable binding of non-target nucleic acids) can be eliminated by secondary shearing, because secondary shearing will only be triggered when primary shearing actually occurs (stable binding).

[0018] 3. Designability and adjustability of secondary signals: The method of the present invention adopts a two-step reaction and signal monitoring, so that the substrate and reaction conditions of the second-step shearing (co-shearing) retain a large space for human design and intervention. For example, when synthesizing the substrate, measures such as introducing artificial group modification or extending the length of the nucleic acid can be adopted, and a sufficient amount of substrate can be added to ensure that the second-step shearing reaction can occur to the greatest extent and continuously, thereby generating a more sufficient secondary signal.

[0019] Methods for solving problems

[0020] The present invention provides the following technical solutions.

[0021] [1] A nucleic acid detection system comprising:

[0022] a substrate comprising a substrate surface and at least two electrodes;

[0023] A linker molecule having a first ligand that binds to the substrate surface and a second ligand that binds to the Cas enzyme;

[0024] A Cas enzyme, wherein the Cas enzyme binds to the second ligand of the linker molecule and forms an enzyme complex with the guide nucleic acid, wherein the Cas enzyme comprises at least one selected from Cas12 (VA type), Cas13 (VI type) and Cas14 (VF type);

[0025] a guide nucleic acid comprising sequences capable of binding to an enzyme and a target nucleic acid, respectively; and

[0026] A reporter nucleic acid comprising a non-specific sequence.

[0027] [2] The nucleic acid detection system according to [1], wherein the Cas enzyme comprises at least one selected from Cas12a, Cas13a, Cas13b, Cas14a, Cas14b and Cas14c.

[0028] [3] The nucleic acid detection system according to [1], wherein the substrate surface is at least one selected from graphene, silicone, germanene, graphene nanoribbon (GNR), double-layer graphene (BLG), phosphorene, tin, graphene oxide, reduced graphene, fluorine graphene, MoS2, gold and carbon.

[0029] [4] The nucleic acid detection system according to [1], wherein the substrate is at least one selected from silicon, silicon oxide, silicon dioxide and paper.

[0030] [5] The nucleic acid detection system according to [1], wherein the substrate is a field effect transistor (FET).

[0031] [6] The nucleic acid detection system according to [1], wherein the linker molecule not bound to the Cas enzyme is blocked.

[0032] [7] The nucleic acid detection system according to [1], wherein the electrode is selected from a source electrode, a drain electrode and a gate electrode.

[0033] [8] The nucleic acid detection system according to [1], wherein the substrate surface is graphene.

[0034] [9] The nucleic acid detection system according to [1], wherein the first ligand is a pyrene ring or a cyclodextrin ring.

[0035]

[10] A nucleic acid detection system according to [1], wherein the second ligand is selected from a hydroxyl group, a carboxyl group, an amine group, an ester group, an amino group, a diethylamino group, an acylide ester group, a boric acid group or an N-hydroxysuccinimide (NHS) group.

[0036]

[11] The nucleic acid detection system according to [1], wherein the linker molecule is 1-pyrenebutyric acid N-hydroxysuccinimide ester (PBASE).

[0037]

[12] A nucleic acid detection system according to [1], wherein the buffer solution remains consistent during the manufacturing process of the nucleic acid detection system.

[0038]

[13] A nucleic acid detection method using the nucleic acid detection system described in any one of [1] to

[12] , the method comprising:

[0039] Adding a sample to be tested to the substrate surface of the nucleic acid detection system;

[0040] applying an electric current to the substrate; and

[0041] The current change on the surface of the substrate is measured, and whether the target nucleic acid exists in the sample to be tested is determined according to the current change.

[0042]

[14] The method according to

[13] , wherein the sample to be tested is urine, blood, serum, cerebrospinal fluid or saliva.

[0043]

[15] A nucleic acid detection system array, comprising:

[0044] a substrate comprising a plurality of substrate surfaces and at least two electrodes;

[0045] A plurality of linker molecules, each of which has a first ligand that binds to the substrate surface and a second ligand that binds to the Cas enzyme;

[0046] A plurality of Cas enzymes, wherein the Cas enzymes bind to the second ligand of the linker molecule and form an enzyme complex with the guide nucleic acid, and the Cas enzymes include at least one selected from Cas12 (VA type), Cas13 (VI type) and Cas14 (VF type);

[0047] A plurality of guide nucleic acids, each of which comprises a sequence capable of binding to a Cas enzyme and a target nucleic acid, wherein the plurality of guide nucleic acids bind to a plurality of the same or different target nucleic acids, respectively; and

[0048] A reporter nucleic acid comprising a non-specific sequence.

[0049]

[16] A nucleic acid detection system array according to

[15] , wherein: the multiple connecting molecules are the same or different from each other.

[0050]

[17] A method for screening candidate guide nucleic acids, using the nucleic acid detection system array described in

[15] , wherein the array comprises a plurality of different candidate guide nucleic acids, the method comprising:

[0051] adding a composition comprising a target nucleic acid to the nucleic acid detection system array;

[0052] applying an electric current to the substrate; and

[0053] The current change on the surface of the substrate is measured, and the guide nucleic acid is screened according to the current change.

[0054] Effects of the Invention

[0055] The present invention can provide a nucleic acid detection system with high sensitivity, high specificity and good applicability. BRIEF DESCRIPTION OF THE DRAWINGS

[0056] Figure 1 Schematic diagram showing the comparison of the cleavage activities of Cas12, Cas13 and Cas9.

[0057] Figure 2 A schematic diagram showing the design of the nucleic acid detection system of the present invention.

[0058] Figure 3 Schematic diagram of a nucleic acid detection system array according to a second embodiment of the present invention.

[0059] Figure 4 Schematic diagram showing the design of the GFET chip used in the embodiment.

[0060] Figure 5 FIG. 4 is an optical micrograph showing a GFET chip used in the examples.

[0061] Figure 6 The results of Raman spectroscopy tests of pristine graphene and PBASE-functionalized graphene are shown.

[0062] Figure 7 To represent the difference in electrical signals between Cas12a-GFET and Cas9-GFET for positive and negative samples in the first step.

[0063] Figure 8 To represent the relationship between the electrical signal of the Cas12a-GFET positive sample in the second step and the added reporter nucleic acid (ssDNA) concentration.

[0064] Reference numerals

[0065] 1 Source electrode

[0066] 2Drain electrode

[0067] 3 Gate electrode

[0068] 4 Graphene

[0069] 5Cas+GFET chip DETAILED DESCRIPTION

[0070] Next, embodiments of the present invention will be described in detail with reference to the drawings, but the present invention is not limited to the embodiments shown in the drawings, and includes all embodiments that satisfy the features described in the claims of the present application.

[0071] <<First Implementation Method>>

[0072] A first embodiment of the present invention relates to a nucleic acid detection system, comprising:

[0073] a substrate comprising a substrate surface and at least two electrodes;

[0074] A linker molecule having a first ligand that binds to the substrate surface and a second ligand that binds to the Cas enzyme;

[0075] A Cas enzyme, wherein the Cas enzyme binds to the second ligand of the linker molecule and forms an enzyme complex with the guide nucleic acid, wherein the Cas enzyme comprises at least one selected from Cas12 (VA type), Cas13 (VI type) and Cas14 (VF type);

[0076] a guide nucleic acid comprising sequences capable of binding to an enzyme and a target nucleic acid, respectively; and

[0077] A reporter nucleic acid comprising a non-specific sequence.

[0078] The above-mentioned Cas enzyme includes at least one Cas enzyme selected from Cas12 (VA type), Cas13 (VI type) and Cas14 (VF type). Specifically, the Cas enzyme is, for example, at least one selected from Cas12a, Cas13a, Cas13b, Cas14a, Cas14b and Cas14c, preferably Cas12a, or Cas13a.

[0079] The following is explained using Cas12 and Cas13 as examples.

[0080] Cas12 and Cas13 are enzymes with associative cleavage activity. Under the guidance of the guide RNA sequence, once Cas12 and Cas 13 bind to the target sequence, they can activate the associative cleavage activity, which will simultaneously cleave the surrounding reporter sequences (such as ssDNA or RNA), thereby causing a second signal change. Figure 1 Schematic diagram showing the comparison of the cleavage activities of Cas12, Cas13 and Cas9. Figure 1 As shown, Cas9 performs a shearing (binding) on ​​a target gene once to generate a signal, while Cas12 and Cas13 have a collateral shearing activity, and after a shearing (binding) on ​​a target gene once, they can also shear the surrounding reporter sequences, and this collateral shearing (binding of ssDNA or RNA with Cas12 enzyme, etc.) can also cause electrical changes in the GFET chip, thereby causing a second signal change.

[0081] Table 1 shows the characteristics of Cas12, Cas13 and Cas9. From the table below, it can be expected that Cas12 and Cas13 have aM level of sensitivity and signal amplification function. Table 1

[0082] Table 1

[0083] LwaCas13a LbaCas13a CcaCas13b PsmCas13b AsCas12a SpyCas9 microorganism L. wadei L.bacterium C. canimorsus P.sp. A.sp. S.pygenes target ssRNA ssRNA ssRNA ssRNA ssRNA / dsDNA dsDNA tracrRNA No No No No No Yes Shear properties Joint activity Joint activity Joint activity Joint activity Joint activity Blunt Sensitivity aM aM aM aM aM f

[0084] Figure 2The schematic diagram of the design of the nucleic acid detection system of the present invention is shown. The figure shows an exemplary graphene field effect transistor (FET) biosensor, which is formed with a source electrode 1 and a drain electrode 2 on a graphene 4, and a gate electrode 3 is arranged therebetween. The biosensor is functionalized by a Cas12 enzyme or / and a Cas13 enzyme compounded with a guide RNA (gRNA), and the biosensor can capture a target nucleic acid bound to the enzyme complex from a sample. When the target sequence is captured, Cas12 or / and Cas13 will shear the reporter nucleic acid, thereby causing a field effect, generating a signal that can be read by a reader such as a lock-in amplifier or a semiconductor parameter analyzer.

[0085] A field effect transistor (FET) is a transistor that controls the flow of current by an electric field. A FET has three terminals: a source electrode, a gate electrode, and a drain electrode. A FET controls the flow of current by applying a voltage to the gate electrode, which in turn changes the conductivity between the drain electrode and the source electrode.

[0086] The three terminals of a FET are:

[0087] Terminal 1: Source electrode (S), through which carriers enter the channel. Usually, the current entering the channel at S is represented by I S express.

[0088] Terminal 2: Drain electrode (D), through which carriers leave the channel. Usually, the current entering the channel at D is represented by I D The drain-source voltage is V DS .

[0089] Terminal 3: Gate electrode (G), which regulates the channel conductivity. By applying voltage to G, I D .

[0090] The nucleic acid detection system of the present invention is composed of a three-terminal graphene-based field effect transistor (FET), which uses graphene as a channel between a source electrode and a drain electrode, wherein a liquid gate electrode is in contact with a nucleic acid sample.

[0091] The substrate surface, substrate, etc. in the nucleic acid detection system of the present invention can adopt the substrate surface, substrate, etc. described in the prior art without particular limitation.

[0092] For example, the substrate surface may be at least one selected from graphene, silicone, germanene, graphene nanoribbons (GNR), double-layer graphene (BLG), phosphorene, tin, graphene oxide, reduced graphene, fluorine graphene, MoS2, gold and carbon, preferably graphene.

[0093] The substrate may be at least one selected from silicon, silicon oxide, silicon dioxide and paper, and is preferably a field effect transistor (FET).

[0094] As the linking molecule used in the present invention, from the viewpoint of connection efficiency with the substrate and the Cas enzyme, and maintaining an appropriate distance from the graphene surface after connection, a pyrene derivative or a cyclodextrin derivative can be used. Among them, the first ligand connecting the linking molecule to the substrate surface can be a pyrene ring or a cyclodextrin ring, and the second ligand bound to the enzyme can be a hydroxyl group, a carboxyl group, an amine group, an ester group, an amino group, a diethylamino group, an amide ester group, a boric acid group or an N-hydroxysuccinimide (NHS) group.

[0095] Specific examples of linker molecules that can be used in the present invention include 1-pyrenebutanoic acid N-hydroxy succinimidyl ester (PBASE), 1-pyrenebutanoic acid (1-PBA), perbenzylated α-cyclodextrin (α-CDBn 18 ), benzyl-β-cyclodextrin (β-CDBn 21 ) or benzylated γ-cyclodextrin (γ-CDBn 24 ) etc., among which PBASE is further preferably used.

[0096] The guide nucleic acid in the nucleic acid detection system of the present invention comprises sequences capable of binding to the Cas enzyme and the target nucleic acid, respectively, and the sequence design can be performed according to the specific Cas enzyme used in the system and the target nucleic acid.

[0097] The reporter sequence in the nucleic acid detection system of the present invention includes a non-specific sequence. For a Cas enzyme with associated shearing activity, the reporter nucleic acid can be any sequence. In addition, there is no particular limitation on the timing of adding the reporter nucleic acid to the system. For example, the reporter nucleic acid can be added to the sample to be tested before adding the sample to the nucleic acid detection system of the present application, or the reporter nucleic acid can be added to the nucleic acid detection system after adding the sample to the nucleic acid detection system of the present application and generating a telecommunication change.

[0098] The manufacturing method of the nucleic acid detection system of the present invention is not particularly limited, but generally includes a graphene-FET sensor manufacturing process and a graphene-FET sensor functionalization process. In the graphene-FET sensor manufacturing process, the graphene is patterned, and a source electrode and a drain electrode are made, and then incorporated into a prepared substrate chip to obtain a graphene-FET sensor. In the functionalization process of the graphene-FET sensor, the graphene surface is functionalized by adding a connecting molecule, and after the connecting molecule is activated, the Cas enzyme is transferred to the graphene surface, and then the unreacted connecting molecule is sealed to obtain the Cas enzyme chip of the present invention, that is, the nucleic acid detection system of the present invention.

[0099] Among them, for the graphene patterning, any technology that can pattern graphene can be used, for example, conventional photolithography technology in the art can be used. For the source electrode and the drain electrode, there is no special limitation, for example, electrodes commonly used in the art, such as Ti / Pt or Cr / Au electrodes, etc. can be used. In the above process, the purpose of activating the linker molecule is to activate the linking group at the end of the linker molecule so that the linker molecule can be easily connected to the Cas enzyme. The compound for activating the linker molecule can be selected according to the specific second ligand in the linker molecule and use a suitable compound known in the art, without special limitations. In addition, in the above process, the purpose of blocking the unreacted linker molecule is to avoid non-specific binding of the unreacted linker molecule to the substance in the sample to be tested, thereby interfering with the subsequent detection of the target nucleic acid. The compound for blocking can be selected according to the specific second ligand in the linker molecule and use a suitable compound known in the art, without special limitations.

[0100] In addition, in the nucleic acid detection system of the present invention, the Cas enzyme can be added to the functionalized graphene surface in the form of an enzyme complex after forming an enzyme complex with the guide nucleic acid, or the Cas enzyme can be added only to the functionalized graphene surface, combined with the connecting molecule, and then the guide nucleic acid is added to form an enzyme complex.

[0101] In addition, during the manufacturing process of the nucleic acid detection system of the present invention, it is preferred to keep the buffer consistent throughout the entire manufacturing process to ensure the activity of the enzyme, thereby avoiding interference with subsequent detection of the target nucleic acid.

[0102] The nucleic acid detection system of the present invention may further include an electronic controller for measuring changes in current on the surface of the substrate.

[0103] The nucleic acid detection system of the present invention can be used to detect target nucleic acids in a sample to be tested. Specifically, the detection may include the following steps: adding the sample to be tested to the substrate surface of the nucleic acid detection system of the present invention; applying current to the substrate; and then measuring the current change on the substrate surface, and judging whether the target nucleic acid is present in the sample to be tested based on the current change. The sample to be tested is not particularly limited, and may be, for example, urine, blood, serum, cerebrospinal fluid, or saliva.

[0104] Below, taking the Cas12a-GFET chip used in the embodiments described later as an example, the design idea of ​​the chip of the present invention is described in detail. It should be noted that this description is only an example and is not a specific limitation of the technical solution of the present invention.

[0105] First, the pyrene ring structure at one end of 1-pyrenebutyric acid N-hydroxysuccinimide ester (PBASE) is used to interact with the π-π of graphene to fix it on the graphene surface; Then, the amino group at the other end of PBASE is reacted with Cas12a to fix Cas12a on the graphene surface. Then, Cas12a fixed on the graphene surface is combined with crRNA (CRISPR-derived RNA) to form a ribonucleoprotein complex (ribonucleoprotein complex, hereinafter also referred to as RNP complex), completing the construction of Cas12a-GFET chip.

[0106] When the nucleic acid to be tested is added to the liquid gate of the GFET, the RNP complex can recognize and bind to the specific nucleic acid sequence. The exposure and pairing process of the charged bases in the nucleic acid can cause changes in the charge in the graphene, changing its carrier state, thereby changing the current in the graphene channel and generating an electrical signal.

[0107] Furthermore, the random sequence ssDNA as the reporter sequence is introduced into the graphene surface, and the activated Cas12a can quickly cut the ssDNA to produce a second signal response, which reconfirms the binding of the target nucleic acid and the RNP complex and improves the accuracy and reliability of the detection.

[0108] Second Implementation Method

[0109] A second embodiment of the present invention relates to a nucleic acid detection system array, comprising:

[0110] a substrate comprising a plurality of substrate surfaces and at least two electrodes;

[0111] A plurality of linker molecules, each of which has a first ligand that binds to the substrate surface and a second ligand that binds to the Cas enzyme;

[0112] A plurality of Cas enzymes, wherein the Cas enzymes bind to the second ligand of the linker molecule and form an enzyme complex with the guide nucleic acid, and the Cas enzymes include at least one selected from Cas12 (VA type), Cas13 (VI type) and Cas14 (VF type);

[0113] A plurality of guide nucleic acids, each of which comprises a sequence capable of binding to an enzyme and a target nucleic acid, and each of which binds to a plurality of the same or different target nucleic acids; and

[0114] A reporter nucleic acid comprising a non-specific sequence.

[0115] Figure 3A nucleic acid detection system array is shown in FIG. 1 , wherein a plurality of independent Cas+GEFT chips 5 are arranged between a source electrode 1 and a drain electrode 2 of a substrate, and in each chip 5, an enzyme complex is bound to the substrate surface by a connecting molecule, and each enzyme complex may be the same or different. For example, Figure 3 As shown, the guide nucleic acid in the first row of chips is designed for the first target nucleic acid, and the row of chips is connected to the first reader; the guide nucleic acid in the second row of chips is designed for the second target nucleic acid, and the row of chips is connected to the second reader, etc. Through the nucleic acid detection system array, multiple target nucleic acids in a sample can be detected simultaneously. The arrangement of the nucleic acid detection system array of the present invention and the target nucleic acid sequence targeted by the enzyme complex therein can be specifically designed by a person skilled in the art according to specific detection needs.

[0116] In addition to being used to simultaneously detect multiple target nucleic acids in a sample to be tested, the nucleic acid detection system array of the present invention can also be used to screen candidate guide nucleic acids. Specifically, for example, a nucleic acid detection system array includes multiple different candidate guide nucleic acids, a composition containing target nucleic acids is added to the system array, an electric current is applied to a substrate, a change in the electric current on the surface of the substrate is measured, and then the guide nucleic acids are screened according to the change in the electric current.

[0117] Example

[0118] The nucleic acid detection system and the nucleic acid detection method of the present invention are specifically illustrated below by taking recombinant blue fluorescent protein (hereinafter also referred to as BFP) as an example, but it should be noted that the present invention is not limited to these embodiments.

[0119] This embodiment aims to combine the CRISPR / Cas12a system and the CRISPR / Cas9 system with GFET, prepare Cas12a-GFET chip and Cas9-GFET chip respectively, and then compare the nucleic acid detection effects of the two.

[0120] 1. Chemical reagents and nucleotide sequences

[0121] The reagents used in the examples are shown in Table 1 below, and the nucleic acid sequences involved are shown in Table 2 below. These nucleic acid sequences were commissioned to be synthesized by Nanjing GenScript Biotechnology Co., Ltd., where N 84 It is a mixture of random sequences consisting of 84 nucleotides.

[0122] It should be noted that the nucleotide "U" in the RNA in Table 2 is represented as "T" in the sequence listing according to the requirements of Wipo Senqunce software.

[0123] Table 1

[0124]

[0125] Table 2

[0126]

[0127] 2. GFET chip

[0128] In this embodiment, a GFET chip designed by ourselves and processed by Spanish Graphenea Company is used. Each chip has three 100μm×100μm single-layer graphene units as channel materials, SiO2 as substrate and 50nm thick Au as electrode. Each graphene unit has an independent drain, and three graphene units share a common source. During the test, the microfluidic liquid chamber with an external Ag-AgCl reference electrode is used as the liquid gate. Figure 4 This is a schematic diagram of the design of the GFET chip.

[0129] 3. Characterization and electrical testing of graphene

[0130] (1) Characterization of graphene

[0131] Graphene was characterized by optical microscopy and Raman spectroscopy.

[0132] During the test, a self-developed microfluidic test system was used, a mold was used to make a PDMS cavity, and a peristaltic pump was used to drive the quantitative liquid inlet. During the test, an Ag-AgCl reference electrode was inserted into the cavity as a liquid gate. The chip was electrically tested during chip characterization and CRISPR reaction.

[0133] (2) Electrical testing

[0134] Electrical testing uses the following two semiconductor testing methods:

[0135] Transfer characteristic curve test: A fixed voltage is applied between the source and drain of the GFET (Vpk=1V in the experiments of this project), and continuously different voltages are applied between the gate and the source to test the changes in source-drain conductance through the graphene channel.

[0136] Time-dependent source-drain conductance test: A fixed voltage is applied between the source and drain of the GFET (Vpk=1V in the experiments of this project), and a fixed voltage is applied between the gate and the source (Vg=0V in the experiments of this project), and the change of source-drain conductance through the graphene channel over time is tested.

[0137] 4. Solution preparation

[0138] Prepare sgRNA stock solution (100 μM) and BFP plasmid stock solution (1 μg / μL) with enzyme-free water;

[0139] Prepare concentrated PBS buffer containing MgCl2: add 100 μL of 100x MgCl2 solution (200 mM) to 1 mL of 10x PBS and mix well;

[0140] Prepare wash solution: 110 μL of PBS concentrated buffer containing MgCl2, add 890 μL of nuclease-free water;

[0141] Prepare a 100 pmol dCas9 protein solution: 5 μL dCas9 protein (20 μM), 11 μL PBS concentrated buffer containing MgCl2, and add 84 μL nuclease-free water to a total volume of 100 μL;

[0142] Prepare 100 μL of sgRNA solution containing 300 pmol (3 times the molar ratio of dCas9): 3 μL of sgRNA stock solution (100 μM), 11 μL of PBS concentrated buffer containing MgCl2, and add 86 μL of nuclease-free water to 100 μL;

[0143] Prepare a BFP plasmid solution containing 2000 ng: 2 μL plasmid stock solution (1 μg / μL), 11 μL PBS concentrated buffer containing MgCl2, and add 87 μL nuclease-free water to a total volume of 100 μL.

[0144] Prepare 100 μL of 1 μM ssDNA probe: 1 μL ssDNA Stock (100 μM), 11 μL PBS concentrated buffer containing MgCl2, and add 88 μL nuclease-free water to 100 μL.

[0145] Example 1: Construction and detection of Cas12a-GFET chip

[0146] (1) Functionalization of GFET

[0147] ① Connecting PBASE bifunctional molecules:

[0148] Wash twice with acetone and once with deionized water. Incubate PBASE (2 mM) dissolved in ethanol on the graphene surface at room temperature for 1 h to functionalize it. Then rinse the surface of the graphene sensor several times with wash solution.

[0149] ②Connect Cas12a and close:

[0150] A solution containing 100 pmol of Cas12a protein was added to the graphene surface (preheated at 37°C) and incubated for 60 min. Then, NH2-PEG5-OH (1 mM, preheated at 37°C) was used to block the unreacted PBASE molecules on the graphene surface. After blocking, the graphene surface was washed with wash solution (preheated to 37°C) and incubated.

[0151] ③Construction of RNP complex:

[0152] The crRNA solution was incubated in a 95°C metal bath for 3 minutes, and then quickly placed in an ice bath for 2 minutes. The heat-treated crRNA solution was preheated to 37°C and incubated on the chip surface for 30 minutes, and then fully washed with a wash solution (preheated to 37°C) to remove unbound crRNA.

[0153] Optical micrograph of a GFET chip Figure 5 As shown. Figure 5 It can be seen that the three graphene areas on the GFET chip are uniform, flat and continuous.

[0154] Raman spectroscopy was performed on pristine graphene and PBASE-functionalized graphene, and the results are shown in Figure 6 .from Figure 6 It can be seen that the graphene of the GFET chip is at 1580cm -1 and 2700cm -1 There are obvious characteristic peaks near the graphene, namely the G peak and 2D peak, indicating that the structure of graphene is complete, and the 2D peak is higher than the G peak, indicating that graphene is a single-layer structure. -1 The D peaks appear on the left and right, indicating that defects appear on the graphene surface, indicating that PBASE has been successfully connected to the graphene surface.

[0155] (2) Signal Detection

[0156] First signal detection: dsDNA target nucleic acid test

[0157] ① The Cas12a-crRNA-BFP functionalized chip was incubated with 2000 ng of BFP plasmid solution (preheated to 37°C) for 30 min, then fully washed with wash solution (preheated to 37°C), and the sensor electrical signal was continuously monitored;

[0158] ② As a negative control, the Cas12a-crRNA-pcsk9 functionalized chip was also incubated with 2000 ng of BFP plasmid for 30 min, then fully washed with wash solution (preheated to 37 °C), and the sensor electrical signal was continuously monitored;

[0159] Second signal detection: ssDNA cleavage activity test

[0160] ① Add 100 μL of 1 μM ssDNA probe to the cleaned Cas12a-GFET chip, continue to detect the signal until it is stable or 1 hour later, wash it thoroughly with wash solution, and continue to detect the sensor signal;

[0161] ② The positive control and negative control were tested using thiolated modified and unmodified ssDNA, respectively.

[0162] In the above signal detection, the changes in the source-drain conductance of the GFET are observed respectively, and the detection results of the first signal detection and the second signal detection are shown in Figure 7 , Figure 8 , where the ordinate is the relative change in GFET source-drain conductance ΔG, which is defined as follows:

[0163]

[0164] Wherein, G represents the source electrode conductance and G0 represents the drain electrode conductance.

[0165] Comparative Example 1: Construction and detection of dCas9-GFET chip

[0166] Cas12a and crRNA used in Example 1 were replaced by dCas9 and sgRNA, respectively, and GFET functionalization and signal detection were performed in the same manner as in Example 1. The results are shown in Figure 7 and Figure 8 .

[0167] Figure 7 The difference in electrical signals between Cas12a-GFET and Cas9-GFET for positive and negative samples after adding the target DNA sample (i.e., the first step) is shown in FIG. Figure 8 The relationship between the electrical signal of the Cas12a-GFET positive sample after adding the reporter sequence (ssDNA) (i.e., the second step) and the concentration of the added reporter nucleic acid (ssDNA) is shown in FIG.

[0168] pass Figure 7 , Figure 8 It can be seen that when the target DNA and reporter sequence (ssDNA) are added respectively, the Cas12a system has a two-step signal change. Compared with Cas9, Cas12a-GFET has higher stability and efficiency in recognizing and binding to target nucleic acids and has higher sensitivity.

[0169] It can be seen that the CRISPR / Cas12a system of the present invention has a significant change in detection signal compared with the CRISPR / Cas9 system, with high sensitivity (higher recognition and binding efficiency of target nucleic acid), good specificity (possible false positive signals are eliminated by two-step signal detection), and good flexibility (the signal of the shearing reaction in the second step can be intervened and adjusted artificially, such as changing the concentration of the substrate and the length of the nucleic acid, as well as changes in chemical modifications to enhance the amplitude of signal changes, etc.).

[0170] The nucleic acid detection system and nucleic acid detection method of the present invention are described above based on the embodiments, but the present invention is not limited to these. As long as it does not depart from the main purpose of the present invention, the various deformation methods that can be thought of by those skilled in the art in the implementation of the embodiments and other methods constructed by combining some of the constituent elements in the embodiments are also included in the scope of the present invention.

Claims

1. A nucleic acid detection system, comprising: a substrate comprising a substrate surface and at least two electrodes; A linker molecule having a first ligand that binds to the substrate surface and a second ligand that binds to the Cas enzyme; A Cas enzyme, wherein the Cas enzyme binds to the second ligand of the linker molecule and forms an enzyme complex with the guide nucleic acid, wherein the Cas enzyme comprises at least one selected from Cas12 (VA type), Cas13 (VI type) and Cas14 (VF type); A guide nucleic acid comprising sequences capable of binding to a Cas enzyme and a target nucleic acid, respectively; and A reporter nucleic acid comprising a non-specific sequence.

2. The nucleic acid detection system according to claim 1, wherein: The Cas enzyme comprises at least one selected from Cas12a, Cas13a, Cas13b, Cas14a, Cas14b and Cas14c.

3. The nucleic acid detection system according to claim 1, wherein: The substrate surface is at least one selected from graphene, silicone, germanene, graphene nanoribbon (GNR), double-layer graphene (BLG), phosphorene, tin, graphene oxide, reduced graphene, fluorine graphene, MoS2, gold and carbon.

4. The nucleic acid detection system according to claim 1, wherein: The substrate is at least one selected from silicon, silicon oxide, silicon dioxide and paper.

5. The nucleic acid detection system according to claim 1, wherein: The substrate is a field effect transistor (FET).

6. The nucleic acid detection system according to claim 1, wherein: Linker molecules that are not bound to the Cas enzyme are blocked.

7. The nucleic acid detection system according to claim 1, wherein: The electrode is selected from a source electrode, a drain electrode and a gate electrode.

8. The nucleic acid detection system according to claim 1, wherein: The substrate surface is graphene.

9. The nucleic acid detection system according to claim 1, wherein: The first ligand is a pyrene ring or a cyclodextrin ring.

10. The nucleic acid detection system according to claim 1, wherein: The second ligand is selected from a hydroxyl group, a carboxyl group, an amine group, an ester group, an amino group, a diethylamino group, an imidoester group, a boric acid group or an N-hydroxysuccinimide (NHS) group.

11. The nucleic acid detection system according to claim 1, wherein: The linker molecule is 1-pyrenebutyric acid N-hydroxysuccinimide ester (PBASE).

12. The nucleic acid detection system according to claim 1, wherein: The buffer remains consistent during the manufacturing process of the nucleic acid detection system.

13. A method for detecting nucleic acid, which uses the nucleic acid detection system according to any one of claims 1 to 12 to detect a target nucleic acid in a sample to be detected, the method comprising: Adding a sample to be tested to the substrate surface of the detection system; applying an electric current to the substrate; and The current change on the surface of the substrate is measured, and whether the target nucleic acid exists in the sample to be tested is determined according to the current change.

14. The method according to claim 13, wherein: The sample to be tested is urine, blood, serum, cerebrospinal fluid or saliva.

15. A nucleic acid detection system array, comprising: a substrate comprising a plurality of substrate surfaces and at least two electrodes; A plurality of linker molecules, each of which has a first ligand that binds to the substrate surface and a second ligand that binds to the Cas enzyme; A plurality of Cas enzymes, wherein the Cas enzymes bind to the second ligand of the linker molecule and form an enzyme complex with the guide nucleic acid, and the Cas enzymes include at least one selected from Cas12 (VA type), Cas13 (VI type) and Cas14 (VF type); A plurality of guide nucleic acids, each of which comprises a sequence capable of binding to a Cas enzyme and a target nucleic acid, wherein the plurality of guide nucleic acids bind to a plurality of the same or different target nucleic acids, respectively; and A reporter nucleic acid comprising a non-specific sequence.

16. The nucleic acid detection system array according to claim 15, wherein: The plurality of linker molecules may be the same as or different from each other.

17. A method for screening candidate guide nucleic acids, using the nucleic acid detection system array of claim 15, wherein: comprising a plurality of different candidate guide nucleic acids, the method comprising: adding a composition comprising a target nucleic acid to the nucleic acid detection system array; applying an electric current to the substrate; and The current change on the surface of the substrate is measured, and the guide nucleic acid is screened according to the current change.